# OnCo record medicare-ncd-110-21 (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/medicare-ncd-110-21/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "medicare-ncd-110-21" ;
  schema:name "Medicare NCD 110.21: erythropoiesis-stimulating agents in cancer"@en ;
  schema:alternateName "NCD 110.21"@en, "Medicare ESA coverage in cancer"@en, "Erythropoiesis Stimulating Agents (ESAs) in Cancer and Related Neoplastic Conditions"@en ;
  schema:description "Medicare pays for epoetin or darbepoetin to treat anaemia caused by chemotherapy only when haemoglobin is below 10 g/dL, at the label starting dose, and stops paying if the blood count does not respond within 8 weeks. It does not pay for these drugs to prevent anaemia, for anaemia from radiotherapy alone, or in leukaemias such as AML and CML."@en ;
  schema:url <https://onco.cc/terms/medicare-ncd-110-21/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?ncdid=322&ncdver=1>, <https://api.coverage.cms.gov/v1/data/ncd?ncdid=322&ncdver=1> ;
  onco:tag "us" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/>, <https://onco.cc/cancers/cll/> ;
  onco:drugs <https://onco.cc/drugs/epoetin-alfa/>, <https://onco.cc/drugs/darbepoetin-alfa/> ;
  onco:institutions <https://onco.cc/institutions/cms/> ;
  onco:terms <https://onco.cc/terms/anaemia/> .